- Report
- April 2026
- 180 Pages
Global
From €4309EUR$4,750USD£3,714GBP
- Report
- January 2026
- 197 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- January 2026
- 150 Pages
Global
From €5398EUR$5,950USD£4,652GBP
- Report
- June 2026
- 193 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- June 2026
- 195 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- June 2026
- 189 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- January 2026
- 188 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- January 2026
- 194 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- January 2026
- 189 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- January 2026
- 186 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- August 2025
- 186 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- August 2025
- 188 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- August 2025
- 198 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- August 2025
- 182 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- August 2025
- 184 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- August 2025
- 189 Pages
Global
From €3216EUR$3,545USD£2,772GBP
€3574EUR$3,939USD£3,080GBP
- Report
- January 2026
- 180 Pages
Global
From €4083EUR$4,500USD£3,518GBP
- Report
- January 2026
- 180 Pages
Global
From €4083EUR$4,500USD£3,518GBP
- Report
- February 2026
- 250 Pages
Global
From €4073EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4073EUR$4,490USD£3,511GBP

Gallium-68 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the production of PET (Positron Emission Tomography) radiopharmaceuticals, which are used to diagnose and treat a variety of diseases. Gallium-68 is produced through the irradiation of enriched zinc-68 in a nuclear reactor, and is then used to produce a variety of PET radiopharmaceuticals. These radiopharmaceuticals are used to diagnose and treat cancer, heart disease, neurological disorders, and other diseases.
Gallium-68 is a key component of the Nuclear Medicine and Radiopharmacology market, and is used in the production of a variety of PET radiopharmaceuticals. Companies in the market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more